These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 23261309)

  • 1. Severity of pulmonary involvement and (18)F-FDG PET activity in sarcoidosis.
    Mostard RL; Verschakelen JA; van Kroonenburgh MJ; Nelemans PJ; Wijnen PA; Vöö S; Drent M
    Respir Med; 2013 Mar; 107(3):439-47. PubMed ID: 23261309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 18F-FDG PET as a predictor of pulmonary function in sarcoidosis.
    Keijsers RG; Verzijlbergen EJ; van den Bosch JM; Zanen P; van de Garde EM; Oyen WJ; Grutters JC
    Sarcoidosis Vasc Diffuse Lung Dis; 2011 Oct; 28(2):123-9. PubMed ID: 22117503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammatory activity assessment by F18 FDG-PET/CT in persistent symptomatic sarcoidosis.
    Mostard RL; Vöö S; van Kroonenburgh MJ; Verschakelen JA; Wijnen PA; Nelemans PJ; Erckens RJ; Drent M
    Respir Med; 2011 Dec; 105(12):1917-24. PubMed ID: 21899998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extent of disease activity assessed by 18F-FDG PET/CT in a Dutch sarcoidosis population.
    Cremers JP; Van Kroonenburgh MJ; Mostard RL; Vöö SA; Wijnen PA; Koek GH; Drent M
    Sarcoidosis Vasc Diffuse Lung Dis; 2014 Apr; 31(1):37-45. PubMed ID: 24751452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A predictive tool for an effective use of (18)F-FDG PET in assessing activity of sarcoidosis.
    Mostard RL; Van Kuijk SM; Verschakelen JA; van Kroonenburgh MJ; Nelemans PJ; Wijnen PA; Drent M
    BMC Pulm Med; 2012 Sep; 12():57. PubMed ID: 22978780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 18F-FDG PET/CT in Pulmonary Sarcoidosis:Quantifying Inflammation by the TLG index.
    Papiris SA; Manali ED; Pianou NK; Kallergi M; Papaioannou AI; Georgakopoulos A; Malagari K; Kelekis NL; Gialafos H; Chatziioannou S
    Expert Rev Respir Med; 2020 Jan; 14(1):103-110. PubMed ID: 31626563
    [No Abstract]   [Full Text] [Related]  

  • 7. FDG PET for gauging of sarcoid disease activity.
    Adams H; Keijsers RG; Korenromp IH; Grutters JC
    Semin Respir Crit Care Med; 2014 Jun; 35(3):352-61. PubMed ID: 25007087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of infliximab in refractory FDG PET-positive sarcoidosis.
    Vorselaars AD; Crommelin HA; Deneer VH; Meek B; Claessen AM; Keijsers RG; van Moorsel CH; Grutters JC
    Eur Respir J; 2015 Jul; 46(1):175-85. PubMed ID: 25929955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Idiopathic pulmonary fibrosis: evaluation with positron emission tomography.
    Meissner HH; Soo Hoo GW; Khonsary SA; Mandelkern M; Brown CV; Santiago SM
    Respiration; 2006; 73(2):197-202. PubMed ID: 16141712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of the PET scan in the management of sarcoidosis.
    Mostard RL; van Kroonenburgh MJ; Drent M
    Curr Opin Pulm Med; 2013 Sep; 19(5):538-44. PubMed ID: 23900129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin-converting Enzyme as a Predictor of Extrathoracic Involvement of Sarcoidosis.
    Yasar Z; Özgül MA; Cetinkaya E; Kargi A; Gül Ş; Talay F; Tanriverdi E; Dincer HE
    Sarcoidosis Vasc Diffuse Lung Dis; 2016 Jan; 32(4):318-24. PubMed ID: 26847099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imaging the inflammatory activity of sarcoidosis: sensitivity and inter observer agreement of (67)Ga imaging and (18)F-FDG PET.
    Keijsers RG; Grutters JC; Thomeer M; Du Bois RM; Van Buul MM; Lavalaye J; Van Den Bosch JM; Verzijlbergen FJ
    Q J Nucl Med Mol Imaging; 2011 Feb; 55(1):66-71. PubMed ID: 21242947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 18F-FDG PET in sarcoidosis: an observational study in 12 patients treated with infliximab.
    Keijsers RG; Verzijlbergen JF; van Diepen DM; van den Bosch JM; Grutters JC
    Sarcoidosis Vasc Diffuse Lung Dis; 2008 Dec; 25(2):143-9. PubMed ID: 19382534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of dual-time-point 18F-fluorodeoxyglucose positron emission tomography in patients with pulmonary sarcoidosis.
    Umeda Y; Demura Y; Morikawa M; Ameshima S; Tsuchida T; Fujibayashi Y; Okazawa H; Ishizaki T
    Respirology; 2011 May; 16(4):713-20. PubMed ID: 21382131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. (18)F-FDG PET/CT for the assessment of disease extension and activity in patients with sarcoidosis: results of a preliminary prospective study.
    Ambrosini V; Zompatori M; Fasano L; Nanni C; Nava S; Rubello D; Fanti S
    Clin Nucl Med; 2013 Apr; 38(4):e171-7. PubMed ID: 23429384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accuracy of individual variables in the monitoring of long-term change in pulmonary sarcoidosis as judged by serial high-resolution CT scan data.
    Zappala CJ; Desai SR; Copley SJ; Spagnolo P; Sen D; Alam SM; du Bois RM; Hansell DM; Wells AU
    Chest; 2014 Jan; 145(1):101-107. PubMed ID: 24051950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The utility of 18F-FDG PET/CT for diagnosis and adjustment of therapy in patients with active chronic sarcoidosis.
    Sobic-Saranovic D; Grozdic I; Videnovic-Ivanov J; Vucinic-Mihailovic V; Artiko V; Saranovic D; Djuric-Stefanovic A; Masulovic D; Odalovic S; Ilic-Dudvarski A; Popevic S; Pavlovic S; Obradovic V
    J Nucl Med; 2012 Oct; 53(10):1543-9. PubMed ID: 22879080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of infliximab biosimilar Inflectra
    Schimmelpennink MC; Vorselaars ADM; van Beek FT; Crommelin HA; Deneer VHM; Keijsers RGM; Veltkamp M
    Respir Med; 2018 May; 138S():S7-S13. PubMed ID: 29496351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Value of 18F-fluorodeoxyglucose-PET in the diagonosis and monitoring of pulmonary sarcoidosis: a case report].
    Kaneko M; Tomioka H; Kaneda T; Kubot M; Tani S; Fujii H; Katsuyama E; Okazaki M
    Nihon Kokyuki Gakkai Zasshi; 2008 Jun; 46(6):505-9. PubMed ID: 18593000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. F-18 FDG PET/CT for detecting bone and bone marrow involvement in sarcoidosis patients.
    Mostard RL; Prompers L; Weijers RE; van Kroonenburgh MJ; Wijnen PA; Geusens PP; Drent M
    Clin Nucl Med; 2012 Jan; 37(1):21-5. PubMed ID: 22157023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.